How Inclusion in Precision Medicine Could Drive Market Success and Minimize Disparities ↗
Lack of diversity in clinical trials and genomic databases doesn't just create health disparities — it creates blind spots that limit the commercial reach of precision medicine. The case for inclusion as both an ethical imperative and a market-expansion strategy.
View on LinkedIn ↗